Report copyright - Q1 2017 Results - BioSyent · Q1 2017 Sales Summary • Q1 2017 pharmaceutical sales of $3.65 million increased 3% over Q1 2016 • FeraMAX® 150 Canadian sales volumes (units) decreased
Please pass captcha verification before submit form